
SynesisAI helps biotech teams speed up protein engineering without sacrificing rigor. It does this with generative AI and advanced computational tools. The company operates as a B2B biotech AI platform for protein engineering, linking to lab workflows and data pipelines. Core technologies include generative AI, computational design, and synthetic biology analytics. The market scope targets biotech and pharmaceutical R&D, aiming to scale protein design across organizations.

SynesisAI helps biotech teams speed up protein engineering without sacrificing rigor. It does this with generative AI and advanced computational tools. The company operates as a B2B biotech AI platform for protein engineering, linking to lab workflows and data pipelines. Core technologies include generative AI, computational design, and synthetic biology analytics. The market scope targets biotech and pharmaceutical R&D, aiming to scale protein design across organizations.